Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease

被引:76
作者
Brownell, AL
Jenkins, BG
Elmaleh, DR
Deacon, TW
Spealman, RD
Isacson, O [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02114 USA
[4] McLean Hosp, Neuroregenerat Labs, Belmont, MA 02178 USA
[5] New England Reg Primate Res Ctr, Southborough, MA 01772 USA
关键词
D O I
10.1038/3300
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We used brain imaging to study long-term neurodegenerative and bioadaptive neurochemical changes in a primate model of Parkinson disease. We gradually induced a selective loss of nigrostriatal dopamine neurons, similar to that of Parkinson disease, by creating oxidative stress through infusion of the mitochondrial complex 1 inhibitor MPTP for 14 +/- 5 months. Repeated evaluations over 3 years by positron emission tomography (PET) demonstrated progressive and persistent loss of neuronal dopamine pre-synaptic re-uptake sites; repeated magnetic resonance spectroscopy (MRS) studies indicated a 23-fold increase in lactate and macromolecules in the striatum region of the brain for up to 10 months after the last administration of MPTP. By 2 years after the MPTP infusions, these MRS striatal lactate and macromolecule values had returned to normal levels. In contrast, there were persistent increases in striatal choline and decreases in N-acetylaspartate. Thus, these combined PET/MRS studies demonstrate patterns of neurochemical changes that are both dynamic and persistent long after selective dopaminergic degeneration.
引用
收藏
页码:1308 / 1312
页数:5
相关论文
共 47 条
[1]   METABOLISM OF HUMAN GLIOMAS - ASSESSMENT WITH H-1 MR SPECTROSCOPY AND F-18 FLUORODEOXYGLUCOSE PET [J].
ALGER, JR ;
FRANK, JA ;
BIZZI, A ;
FULHAM, MJ ;
DESOUZA, BX ;
DUHANEY, MO ;
INSCOE, SW ;
BLACK, JL ;
VANZIJL, PCM ;
MOONEN, CTW ;
DICHIRO, G .
RADIOLOGY, 1990, 177 (03) :633-641
[2]   USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS [J].
ARNOLD, DL ;
RIESS, GT ;
MATTHEWS, PM ;
FRANCIS, GS ;
COLLINS, DL ;
WOLFSON, C ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1994, 36 (01) :76-82
[3]   N-ACETYL-L-ASPARTIC ACID - A LITERATURE-REVIEW OF A COMPOUND PROMINENT IN H-1-NMR SPECTROSCOPIC STUDIES OF BRAIN [J].
BIRKEN, DL ;
OLDENDORF, WH .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1989, 13 (01) :23-31
[4]  
Brooks D. J., 1993, Neurology, V43, pS6
[5]  
Brownell AL, 1996, J NUCL MED, V37, P1186
[6]  
Brownell G. L., 1989, International Journal of Imaging Systems and Technology, V1, P207, DOI 10.1002/ima.1850010210
[7]  
BROWNELL GL, 1985, METABOLISM HUMAN BRA, P13
[8]   LOSS OF STRIATAL NEURONS IN PARKINSONS-DISEASE - A CYTOMETRIC STUDY [J].
BUGIANI, O ;
PERDELLI, F ;
SALVARANI, S ;
LEONARDI, A ;
MANCARDI, GL .
EUROPEAN NEUROLOGY, 1980, 19 (05) :339-344
[9]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[10]  
CALNE DDB, 1985, NATURE, V317, P244